MedPath
HSA Approval

SENNA TABLET 7.5 mg

SIN02550P

SENNA TABLET 7.5 mg

SENNA TABLET 7.5 mg

April 19, 1989

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A06AB06

senna glycosides

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

REMEDICA LTD

Active Ingredients

Sennosides 60% 12.50 mg eqv sennosides

7.5 mg

Sennosides

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SENNA TABLET 7.5 mg - HSA Approval | MedPath